Bicycle Therapeutics (BCYC) Amortization of Deferred Charges (2021 - 2024)
Bicycle Therapeutics (BCYC) posted Amortization of Deferred Charges of $107000.0 for Q2 2024, up 2.88% on a QoQ basis from $104000.0 in Q1 2024, and up 11.46% year-over-year from $96000.0 in Q3 2023.
Bicycle Therapeutics (BCYC) Amortization of Deferred Charges (2021 - 2024) Analysis & Trends
Bicycle Therapeutics' Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $107000.0 for Q2 2024.
- Quarterly Amortization of Deferred Charges rose 11.46% year-over-year to $107000.0 in Q2 2024, while the trailing twelve-month figure through Dec 2024 was $211000.0 (down 44.91% YoY) and the FY2024 annual result came in at $211000.0, down 44.91% from the prior year.
- Amortization of Deferred Charges was $107000.0 for Q2 2024 at Bicycle Therapeutics, up from $104000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $136000.0 in Q2 2022 and bottomed at $83000.0 in Q4 2022.
- A 4-year average of $107428.6 and a median of $103000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Peak annual rise in Amortization of Deferred Charges reached 45.16% in 2022, while the deepest fall reached 31.4% in 2022.
- Bicycle Therapeutics' Amortization of Deferred Charges stood at $121000.0 in 2021, then sank by 31.4% to $83000.0 in 2022, then increased by 13.25% to $94000.0 in 2023, then gained by 13.83% to $107000.0 in 2024.
- Business Quant data shows BCYC's Amortization of Deferred Charges at $107000.0 in Q2 2024, $104000.0 in Q1 2024, and $94000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 104,000.00 |
| Mar 31, 2024 | 104,000.00 |
| Dec 31, 2023 | 94,000.00 |
| Dec 31, 2023 | 94,000.00 |
| Sep 30, 2023 | 91,000.00 |
| Sep 30, 2023 | 91,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Jun 30, 2023 | 96,000.00 |
| Mar 31, 2023 | 102,000.00 |
| Mar 31, 2023 | 102,000.00 |
| Dec 31, 2022 | 83,000.00 |
| Dec 31, 2022 | 83,000.00 |
| Sep 30, 2022 | 88,000.00 |
| Sep 30, 2022 | 88,000.00 |
| Jun 30, 2022 | 136,000.00 |
| Jun 30, 2022 | 136,000.00 |
| Mar 31, 2022 | 135,000.00 |
| Mar 31, 2022 | 135,000.00 |